Benchmark against your competition
Understand how AI crawlers access your site
See where AI gets info about you
Track the queries mentioning your brand
Own your AI narrative
Add GEO to your service offerings
Get recommended in shopping queries
Monitor AI mentions at scale
Granata Bio aims to improve access to fertility treatments by introducing new medications and therapies for reproductive health. With a strong emphasis on clinical development and commercialization, the company seeks to address the barriers faced by patients in the US fertility market.
Claim this profile to keep your information accurate and add what's missing.
A range of medications and therapies designed to support various stages of assisted reproductive technology (ART), including ovarian stimulation and luteal phase support.
Granata Bio's mission is to create access for fertility patients by introducing new therapeutic solutions to improve reproductive health.
Granata Bio was founded in 2018.
Granata Bio aims to address the high costs of fertility treatments and the limited insurance coverage available for such services.
The Granata Bio team has over 130 years of combined experience in women's health and reproductive health.
Granata Bio focuses on identifying and in-licensing strategic medications used in IVF outside of the US for clinical development and commercialization.